Amanote Research
Register
Sign In
Government Insists NHS Pays for Drugs Approved by NICE
BMJ
doi 10.1136/bmj.323.7326.1386
Full Text
Open PDF
Abstract
Available in
full text
Date
December 15, 2001
Authors
Z. Kmietowicz
Publisher
BMJ
Related search
Php365 - Trends and Characteristics of Managed Access Agreements Approved by Nice
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Drug Development Process and Novel Drugs Approved by FDA for 2017 -18
Applied Clinical Research, Clinical Trials and Regulatory Affairs
Repurposing FDA-approved Drugs for Anti-Aging Therapies
Biogerontology
Aging
Gerontology
Geriatrics
Limiting Prescribable NHS Drugs
BMJ
Opportunity Costs of Implementing Nice Decisions in NHS Wales
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Opportunity Costs of Implementing Nice Decisions in NHS Wales
SSRN Electronic Journal
Pivotal Studies of Orphan Drugs Approved for Neurological Diseases
Annals of Neurology
Neurology
NHS Faces Legal Action Over Copayment for Private Drugs While Receiving NHS Care
British Medical Journal
Medicine
Off-Label Use of Approved Drugs
Nature Reviews Clinical Oncology
Oncology